Skip to content

A study to determine if Electral-Z Plus, an oral rehydration drink containing zinc, is more effective than standard treatment in improving recovery from dehydration due to fever among participants.

Effectiveness and safety of low osmolar oral rehydration solution plus zinc (Electral-Z Plus) in patients with fever-induced dehydration A pilot study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097649
Enrollment
60
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E860- Dehydration

Interventions

Intervention1: Not Applicable: Not Applicable Intervention2: NA: NA Intervention3: Nil: Nil Intervention4: Nil: Nil Control Intervention1: Not Applicable: Not Applicable

Sponsors

FDC Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age groups between greater than or equal to 12 and less than 65 years 2. Patients with the onset of fever less than or equal to 72 hours 3. Patients with moderate dehydration based on the clinical dehydration scale

Exclusion criteria

Exclusion criteria: 1. Patients with onset of fever greater than 3 days 2. Patients on any other oral rehydration salts 3. Patients with mild and severe dehydration, having a cumulative score less than 8 and greater than 14, respectively, on the clinical dehydration scale 4. Patients under treatment with other antioxidants (for example, vitamin C, vitamin E, beta carotene, and other related carotenoids, along with the minerals selenium, zinc from other supplements, and manganese) 5. Patients who are hospitalized with intravenous (IV) rehydration therapy 6. Patients suffering from diarrhea without fever 7. Patients who are immunocompromised 8. Underlying severe chronic diseases, such as chronic kidney disease (CKD), chronic liver disease (CLD), congestive heart failure (CHF), severe respiratory diseases like chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, cancer, autoimmune diseases requiring immunosuppressive therapy, end stage neurological disorders, and severe malnutrition 9. Clinical signs of a coexisting severe acute systemic illness (meningitis, sepsis, pneumonia) and any clinical signs that may interfere with the treatment as per the investigators opinion 10. Patients with hypersensitivity to any ingredients of Electral Z plus or contraindicated to Electral Z plus

Design outcomes

Primary

MeasureTime frame
1. To evaluate the effectiveness of low osmolar oral rehydration solution plus zinc (Electral-Z Plus) in patients with fever-induced dehydration compared to standard of careTimepoint: 1. Baseline and 1 Week

Secondary

MeasureTime frame
1. To assess the treatment outcomes of low osmolar oral rehydration solution plus zinc (Electral-Z Plus) in patients with fever-induced dehydration compared to the standard of care 2. To evaluate the safety of low osmolar oral rehydration solution plus zinc (Electral-Z Plus) in patients with fever-induced dehydrationTimepoint: 1. 6 2 days 2. 6 2 days

Countries

India

Contacts

Public ContactMr Gopal Kadam

FDC Limited

kalpesh.dalvi@fdcindia.com02226739347

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026